# KUPI Reproductive Endocrinology & Infertility Lab – FDA Inspection, Mar 6, 2023

Source: https://www.keypedia.com/records/fda_inspections/kupi-reproductive-endocrinology-infertility-lab/fb460932-0cce-444f-8e36-4760be4d18ea
Source feed: FDA_Inspections

> FDA inspection 1199015 of KUPI Reproductive Endocrinology & Infertility Lab, March 06, 2023. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 1271. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1199015
- Company Name: KUPI Reproductive Endocrinology & Infertility Lab
- Inspection Date: 2023-03-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1240683 - 2024-05-16
- FDA Inspection 1055208 - 2018-05-02
- FDA Inspection 969078 - 2016-04-29
- FDA Inspection 889600 - 2014-07-31
- FDA Inspection 761532 - 2012-01-09

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/william-f-lagud/c90c4bd6-bb56-4a60-a5f8-cbc648bb8dbe)

Company: https://www.keypedia.com/companies/kupi-reproductive-endocrinology-infertility-lab/d91e2a63-cd00-43ee-a695-8906a065991b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
